essenti
oil
complex
natur
mixtur
main
constitu
eg
terpen
phenylpropanoid
respons
biolog
properti
essenti
oil
eucalyptu
tea
tree
thyme
major
monoterpen
compound
aterpinen
gterpinen
apinen
pcymen
aterpineol
thymol
citral
examin
antivir
activ
herp
simplex
viru
type
vitro
essenti
oil
abl
reduc
viral
infect
monoterpen
inhibit
hsv
mode
antivir
action
determin
moder
antivir
effect
reveal
essenti
oil
monoterpen
drug
ad
host
cell
prior
infect
entri
hsv
cell
howev
essenti
oil
monoterpen
exhibit
high
activ
direct
inactiv
free
viru
particl
test
drug
interact
dosedepend
manner
herpesviru
particl
therebi
inactiv
viral
infect
among
analys
compound
monoterpen
hydrocarbon
slightli
superior
monoterpen
alcohol
antivir
activ
apinen
aterpineol
reveal
highest
select
index
howev
mixtur
differ
monoterpen
present
natur
tea
tree
essenti
oil
reveal
tenfold
higher
select
index
lower
toxic
isol
singl
monoterpen
copyright
essenti
oil
odour
volatil
product
plant
secondari
metabol
wide
applic
folk
medicin
well
fragranc
industri
essenti
oil
complex
natur
mixtur
volatil
secondari
metabolit
isol
plant
distil
main
constitu
essenti
oil
eg
monoterpen
sesquiterpen
phenylpropanoid
includ
carbohydr
alcohol
ether
aldehyd
keton
respons
fragrant
biolog
properti
aromat
medicin
plant
herp
simplex
viru
hsv
differenti
two
antigen
type
type
type
import
pathogen
human
therefor
discoveri
novel
antihsv
drug
deserv
great
effort
hsv
infect
replic
cell
site
entri
mucocutan
surfac
acut
ganglion
infect
subsid
hsv
establish
latenc
persist
neuron
lifetim
latent
viru
reactiv
spontan
caus
frequent
recurr
infect
patient
peopl
experi
recurr
infect
common
reactiv
mostli
affect
adult
peopl
whitley
roizman
primari
symptom
herp
infect
includ
prodrom
fl
ulik
syndrom
fever
headach
malais
diffus
myalgia
follow
local
symptom
consist
itch
pain
papul
gingivostomat
pharyng
frequent
clinic
manifest
fi
rst
episod
infect
clinic
manifest
diseas
exhibit
differ
sever
immunocompet
patient
addit
patient
alway
encount
recurr
attack
whitley
roizman
antivir
agent
acyclovir
famciclovir
valacyclovir
use
shorten
cours
decreas
sever
clinic
symptom
may
suppress
viru
whitley
roizman
antivir
agent
licens
current
treatment
herpesviru
infect
includ
acyclovir
deriv
foscarnet
cidofovir
inhibit
herpesviru
dna
polymeras
de
clercq
addit
emerg
viru
strain
resist
commonli
use
antiherpesviru
drug
import
particularli
immunocompromis
patient
reusser
cassadi
whitley
develop
viral
resist
toward
antivir
agent
enhanc
need
new
effect
compound
viral
infect
medicin
plant
produc
varieti
chemic
constitu
abil
inhibit
viral
replic
compound
natur
sourc
interest
possibl
sourc
control
viral
infect
antiherp
screen
experi
medicin
plant
extract
plant
deriv
secondari
metabolit
report
reichl
et
al
de
logu
et
al
antiherp
activ
sever
essenti
oil
differ
plant
sourc
well
constitu
essenti
oil
demonstr
previous
farag
et
al
applic
tea
tree
oil
essenti
oil
melaleuca
alternifolia
treatment
recurr
herp
labiali
report
recent
carson
et
al
antiherp
activ
eucalyptu
oil
australian
tea
tree
oil
schnitzler
et
al
thyme
oil
schnitzler
et
al
manuka
oil
reichl
et
al
publish
previous
phenylpropan
benencia
tragoolpua
jatisatienr
triterpen
niedermey
et
al
sesquiterpen
hayashi
et
al
pusztai
et
al
rolling
et
al
test
antivir
activ
differ
herpesvirus
rhinoviru
howev
monoterpen
major
constitu
essenti
oil
analys
systemat
antivir
potenti
report
describ
inhibit
viral
replic
monoterpen
eg
isoborneol
potent
inhibitor
hsv
armaka
et
al
consequ
littl
inform
terpen
concern
inhibit
viral
replic
cycl
mode
antivir
action
goal
present
studi
evalu
antivir
activ
monoterpen
major
constitu
essenti
oil
mode
antivir
action
monoterpen
viral
multipl
cycl
essenti
oil
monoterpen
essenti
oil
test
met
standard
demand
either
current
pharmacopoeia
literatur
data
blaschek
et
al
eucalyptu
oil
tea
tree
oil
provid
primavera
life
sulzberg
germani
thyme
oil
obtain
caelo
hilden
germani
monoterpen
pcymen
citral
ciscitr
transcitr
thymol
purchas
roth
karlsruh
germani
monoterpen
met
high
puriti
standard
high
content
eucalyptu
oil
tea
tree
oil
pcymen
thymol
thyme
oil
citral
lemon
oil
report
previous
reichl
et
al
structur
formula
select
monoterpen
constitu
present
fig
essenti
oil
monoterpen
dissolv
ethanol
dilut
medium
cell
cultur
experi
alway
result
ethanol
concentr
effect
cell
virus
schnitzler
et
al
acyclovir
acyclovir
purchas
glaxosmithklin
bad
oldeslo
germani
dissolv
steril
water
cell
cultur
herp
simplex
viru
type
cell
african
green
monkey
kidney
cell
grown
monolay
cultur
dulbecco
modifi
ed
eagl
medium
dmem
supplement
fetal
calf
serum
fc
uml
penicillin
streptomycin
monolay
remov
plastic
surfac
serial
passag
whenev
becam
confl
uent
cell
plate
onto
cultur
plate
cytotox
antivir
assay
respect
propag
atmospher
co
herp
simplex
viru
type
strain
ko
use
experi
virus
routin
grown
cell
viru
stock
cultur
prepar
supernat
infect
cell
store
infect
titer
determin
standard
plaqu
assay
confl
uent
cell
cytotox
assay
cytotox
assay
cell
seed
plate
incub
h
medium
remov
fresh
dmem
contain
appropri
dilut
essenti
oil
monoterpen
ad
onto
subconfl
uent
cell
eight
replic
concentr
drug
well
contain
medium
ethanol
drug
also
includ
plate
control
day
incub
growth
medium
remov
viabil
drug
treat
cell
determin
standard
neutral
red
assay
et
al
neutral
red
dye
uptak
determin
measur
optic
densiti
od
elut
neutral
red
nm
spectrophotomet
mean
od
cellcontrol
well
assign
valu
cytotox
concentr
drug
reduc
viabl
cell
number
tc
determin
doserespons
curv
addit
maximum
noncytotox
concentr
drug
determin
doserespons
assay
inhibit
hsv
replic
measur
plaqu
reduct
assay
usual
plaqu
form
unit
pfu
incub
differ
concentr
essenti
oil
monoterpen
h
room
temperatur
viru
allow
adsorb
cell
h
residu
inoculum
discard
infect
cell
overlaid
medium
contain
methylcellulos
concentr
perform
three
replic
virusinfect
cell
well
contain
medium
ethanol
drug
also
includ
plate
control
incub
day
monolay
fi
xed
formalin
cultur
stain
crystal
violet
subsequ
plaqu
count
refer
number
plaqu
observ
viru
control
monolay
untreat
cultur
concentr
test
compound
inhibit
plaqu
number
ic
determin
doserespons
curv
time
addit
assay
order
determin
mode
antivir
action
oil
monoterpen
cell
pretreat
essenti
oil
compon
viral
infect
virus
incub
drug
infect
infect
cell
incub
immedi
penetr
viru
cell
essenti
oil
compon
alway
use
maximum
noncytotox
concentr
cell
monolay
pretreat
drug
prior
inocul
viru
ad
essenti
oil
compon
cultur
medium
follow
incub
h
drug
aspir
cell
wash
hsv
inoculum
ad
pretreat
herp
simplex
viru
drug
pfu
hsv
incub
medium
contain
maximum
noncytotox
concentr
drug
h
room
temperatur
prior
infect
cell
effect
essenti
oil
compon
hsv
also
test
replic
period
addit
drug
cell
infect
overlay
medium
typic
perform
antivir
suscept
studi
assay
run
three
replic
plaqu
reduct
assay
carri
describ
number
plaqu
drugtreat
cell
virus
compar
untreat
control
well
contain
medium
ethanol
drug
also
includ
plate
control
eucalyptu
oil
tea
tree
oil
thyme
oil
select
monoterpen
compound
fig
serial
dilut
ethanol
ad
cell
cultur
medium
examin
effect
growth
viabil
tissu
cultur
cell
alway
result
ethanol
concentr
effect
cell
virus
cell
monolay
grown
medium
contain
differ
concentr
drug
day
incub
cell
viabil
cell
determin
neutral
red
assay
tabl
maximum
noncytotox
concentr
drug
determin
citral
least
toxic
compound
test
essenti
oil
monoterpen
reveal
low
cytotox
potenti
antivir
effect
differ
essenti
oil
select
compon
determin
herp
simplex
viru
type
vitro
incub
h
room
temperatur
variou
concentr
eucalyptu
oil
tea
tree
oil
thyme
oil
pcymen
thymol
citral
assay
untreat
virusinfect
cell
use
control
subsequ
aliquot
dilut
ad
cell
h
afterward
cell
wash
overlaid
drugfre
medium
incub
day
inhibitori
concentr
ic
determin
wide
rang
tea
tree
oil
tabl
result
present
viru
reduct
repres
averag
three
independ
experi
plaqu
reduct
assay
essenti
oil
monoterpen
exhibit
concentrationdepend
antivir
effect
tea
tree
oil
effect
drug
essenti
oil
abl
suppress
viral
multipl
tabl
monoterpen
inhibit
hsv
except
less
activ
tabl
result
shown
monoterpen
maximum
noncytotox
concentr
beyond
data
shown
select
indic
oil
differ
monoterpen
calcul
tc
ic
ratio
tabl
highest
select
index
determin
tea
tree
oil
low
select
indic
found
eucalyptu
oil
thyme
oil
monoterpen
herpesviru
replic
character
complex
sequenc
differ
step
antivir
agent
might
interfer
order
investig
inhibitori
effect
herp
simplex
viru
detail
drug
ad
differ
stage
viral
infect
comparison
untreat
control
contain
concentr
ethanol
drugtreat
virus
order
exclud
infl
uenc
ethanol
host
cell
pretreat
drug
prior
infect
test
drug
show
minor
effect
viral
infect
eg
eucalyptu
oil
tea
tree
oil
fig
hand
pretreat
oil
monoterpen
compound
h
prior
infect
caus
signifi
cant
reduct
plaqu
format
maximum
noncytotox
concentr
test
drug
infect
reduc
essenti
oil
well
three
monoterpen
fig
except
constitu
reveal
plaqu
reduct
herp
simplex
viru
acyclovir
show
highest
antivir
activ
ad
replic
period
inhibit
viral
replic
drug
inhibit
specifi
calli
viral
dna
polymeras
replic
cycl
new
viral
dna
synthes
howev
minor
effect
viral
infect
detect
cell
virus
pretreat
acyclovir
data
shown
contrast
oil
compound
ad
overlay
medium
penetr
virus
host
cell
plaqu
format
signifi
cantli
reduc
moder
effect
fig
pharmaceut
industri
increasingli
target
medicin
plant
aim
identifi
lead
compound
focus
particularli
suitabl
altern
antivir
agent
sever
drug
current
avail
manag
hsv
infect
acyclovir
topic
treatment
herp
labiali
infect
standard
part
carri
acyclovir
cream
also
phytotherapeut
prepar
contain
sage
oil
lemon
balm
oil
saller
et
al
leonhardt
koytchev
et
al
plant
essenti
oil
shown
significantli
superior
placebo
equival
acyclovir
leonhardt
previou
vitro
experi
reveal
similar
result
essenti
oil
eucalyptu
tea
tree
thyme
schnitzler
et
al
schuhmach
et
al
koch
et
al
present
studi
inhibitori
effect
sever
essenti
oil
herp
simplex
viru
infect
compar
antivir
potenti
major
monoterpen
compound
test
essenti
oil
monoterpen
exhibit
high
level
antivir
activ
viral
suspens
test
maximum
noncytotox
concentr
plaqu
format
signifi
cantli
reduc
eucalyptu
oil
tea
tree
oil
thyme
oil
monoterpen
constitu
abl
suppress
viral
infect
high
antivir
activ
observ
essenti
oil
isol
monoterpen
herpesviru
incub
drug
prior
host
cell
infect
result
suggest
investig
drug
directli
inactiv
herp
viru
might
interfer
virion
envelop
structur
mask
viral
structur
necessari
adsorpt
entri
host
cell
virucid
activ
melaleuca
armillari
essenti
oil
report
recent
farag
et
al
dissolut
hsv
envelop
treatment
oregano
essenti
oil
describ
siddiqui
et
al
thu
differ
mechan
antivir
activ
differ
essenti
oil
seem
present
inhibit
hsv
test
essenti
oil
monoterpen
appear
occur
adsorpt
penetr
viru
cell
remain
determin
whether
inhibitori
effect
essenti
oil
due
bind
essenti
oil
viral
protein
involv
host
cell
adsorpt
penetr
de
logu
et
al
report
inactiv
herpesvirus
prevent
cell
cell
spread
santolina
insulari
essenti
oil
howev
antivir
effect
observ
intracellular
replic
phase
accord
result
essenti
oil
monoterpen
adenoviru
viru
without
envelop
affect
eucalyptu
essenti
oil
due
lack
viral
envelop
cermelli
et
al
sesquiterpen
eg
triptofordin
sesquiterpen
coumarin
inhibit
cytomegaloviru
hayashi
et
al
sever
acut
respiratori
syndrom
coronaviru
wen
et
al
rhinoviru
rolling
et
al
pusztai
et
al
report
specifi
c
inhibit
cmv
immedi
earli
gene
express
wherea
sesquiterpen
moder
virucid
differ
envelop
virus
eg
herp
simplex
viru
cytomegaloviru
measl
viru
infl
uenza
viru
hayashi
et
al
isoborneol
monoterpen
compon
sever
plant
essenti
oil
show
virucid
activ
specifi
calli
inhibit
glycosyl
viral
protein
armaka
et
al
applic
cineol
protect
mice
infect
bourn
et
al
sinc
essenti
oil
abl
inhibit
acyclovirresist
isol
schnitzler
et
al
mechan
interact
compound
acyclovir
hsv
must
differ
acyclovir
inhibit
viru
replic
interfer
dna
polymeras
insid
cell
wherea
essenti
oil
monoterpen
probabl
inactiv
hsv
enter
cell
viral
resist
acyclovir
repres
particular
problem
preval
resist
acyclovirtr
immunocompromis
individu
approxim
christoph
et
al
stranska
et
al
therefor
antiherpet
agent
effect
viral
mutant
resist
current
antivir
agent
great
interest
topic
treatment
applic
tea
tree
oil
essenti
oil
melaleuca
alternifolia
treatment
recurr
herp
labiali
report
recent
carson
et
al
carson
et
al
princip
activ
compon
tea
tree
oil
activ
antibacteri
timekil
assay
isol
compound
present
tea
tree
oil
cox
et
al
fi
nding
contrast
result
antivir
activ
complex
mixtur
essenti
oil
reveal
higher
antivir
activ
select
index
wherea
singl
major
monoterpen
reveal
low
select
indic
respect
rather
low
select
indic
monoterpen
permit
topic
applic
mucou
membran
test
monoterpen
domin
toxic
essenti
oil
eg
eucalyptu
oil
consist
reveal
low
toxic
also
low
select
indic
thyme
oil
tc
correspond
well
major
compound
pcymen
thymol
tc
valu
rang
true
tea
tree
oil
main
constitu
contribut
equal
fi
nal
tc
mixtur
essenti
oil
taken
togeth
composit
monoterpen
essenti
oil
domin
toxic
activ
howev
antivir
activ
singl
monoterpen
contribut
equal
antivir
activ
essenti
oil
tea
tree
oil
compos
although
major
compound
tea
tree
oil
reveal
much
lower
antivir
activ
complex
oil
demonstr
high
antivir
activ
co
et
al
co
et
al
recommend
ic
valu
promis
natur
product
infecti
diseas
eg
extract
pure
compound
essenti
oil
studi
reveal
ic
valu
eucalyptu
tea
tree
thyme
respect
far
recommend
cut
howev
monoterpen
citral
reveal
ic
valu
suggest
cut
monoterpen
display
higher
ic
valu
present
promis
antiinfect
agent
accord
suggest
howev
import
predict
valu
futur
applic
drug
select
index
amoro
et
al
recommend
select
index
least
appropri
accord
suggest
essenti
oil
monoterpen
except
thymol
might
suitabl
agent
howev
drug
higher
select
prefer
vanden
bergh
et
al
eg
tea
tree
oil
alreadi
success
appli
labial
herp
infect
compound
essenti
oil
need
screen
mixtur
differ
compound
essenti
oil
seem
superior
prefer
singl
compound
consid
lipophil
natur
tea
tree
oil
enabl
penetr
skin
promis
topic
therapeut
agent
treatment
recurr
herp
infect
